Concepedia

Shi‐Long Lu

SL

Statistics

Publications

50

Citations

4.2K

H-Index

30

Active since

1995

Affiliations

Oregon Health & Science University(Current)

University of Colorado Anschutz Medical Campus

University of Colorado Denver

China Medical University

First Hospital of China Medical University

Shi‐Long Lu is an author at Oregon Health & Science University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1995–2023

50

Publications

50

CIP2A Inhibits PP2A in Human Malignancies

Melissa R. Junttila, Pietri Puustinen, Minna Niemelä et al. · Cell · 2007 · 681 citations · Full text

, , +4

Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene

Wei-Dong Chen, Zhifen Han, Joel Skoletsky et al. · JNCI Journal of the National Cancer Institute · 2005 · 370 citations · Full text

, , +17

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers

Min Yan, Ronald M. Rerko, Petra Platzer et al. · Proceedings of the National Academy of Sciences · 2004 · 243 citations · Full text

, , +16

Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation

Sophia Bornstein, Ruth A. White, Stephen P. Malkoski et al. · Journal of Clinical Investigation · 2009 · 217 citations · Full text

, , +17

Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression

Kristina E. Hoot, Jessyka G. Lighthall, Gangwen Han et al. · Journal of Clinical Investigation · 2008 · 208 citations · Full text

, , +17

1–5 of 50